Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Easy, thanks for your valuable insights. Like you I've been here what seems to be an eternity (since 2009) and nearly lost it all around the reverse split but it finally looks like things are shaping up and the stock is now beginning its climb to more fair value. The challenge over the coming months IMO will be patience, since a +$30 stock price when we get back to that level might look like nice paper profit to many, but it is still only a fraction of what the company is worth ($30 equates to roughly a $1 billion valuation for ADXS). With this latest Amgen deal, I think Dan O'Connor is signaling that he was serious when he told shareholders at the annual meeting a couple years ago that he thought ADXS could be valued on par with ImClone, which was sold for $6.5 billion. GLTA